Iza-Bren EGFR×HER3 bispecific ADC at ESMO 2025: Phase III BL-B01D1-303 results in …

By /

The preplanned interim analysis (IA)used a data cutoff of March 30, 2025. Between December 4, 2023 and February 21, 2025, 386 patients were …

More »

Leave a Comment

Your email address will not be published. Required fields are marked *

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by
Scroll to Top